Trials / Unknown
UnknownNCT01125020
Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to investigate the effect of postoperative adjuvant chemotherapy in prevention of tumor recurrence and metastasis for hepatocellular carcinoma after liver transplantation.
Conditions
- Liver Transplantation
- Hepatocellular Carcinoma
- Tumor Recurrence and Metastasis
- Survival
- Adjuvant Chemotherapy
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gemcitabine and oxaliplatin | Gemcitabine 1000mg/m2 (days l, 8) and oxaliplatin 130mg/m2 (day l) delivered as an intravenous infusion, given every 28days and repeat six times. |
| DRUG | doxorubicin, 5-Fu and cisplatin | Doxorubicin 20mg/m2 (days 1, 3), 5-Fu 300mg/m2 (days 1-5) and cisplatin 20mg/m2 (days 1-3) delivered as an intravenous infusion, given every 28days and repeat six times. |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2010-05-01
- Completion
- 2010-12-01
- First posted
- 2010-05-18
- Last updated
- 2010-05-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01125020. Inclusion in this directory is not an endorsement.